High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021
JAMA Pediatrics · 2023
DOI: 10.1001/jamapediatrics.2022.4131 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Pediatrics, 2023. Verfasst von Kavya Pathak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Device Approval, Product Surveillance, Postmarketing. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
This cohort study examines the characteristics of high-risk therapeutic devices approved by the US Food and Drug Administration for use in children and adolescents between 2016 and 2021.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Harvard Medical School, Boston, Massachusetts.
- Computational Health Informatics Program, Boston Children's Hospital, Boston, Massachusetts.
- Division of Urological Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
- Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California.
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.
Zitieren
APA
Pathak, K., Narang, C., Hwang, T. J., Espinoza, J. C., & Bourgeois, F. T. (2023). High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2022.4131
Vancouver
Pathak K, Narang C, Hwang TJ, Espinoza JC, Bourgeois FT. High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021. JAMA Pediatrics. 2023. doi:10.1001/jamapediatrics.2022.4131
BibTeX
@article{Pathak2023,
author = {Pathak, Kavya and Narang, Claire and Hwang, Thomas J and Espinoza, Juan C and Bourgeois, Florence T},
title = {High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021},
journal = {JAMA Pediatrics},
year = {2023},
doi = {10.1001/jamapediatrics.2022.4131}
}
EUVIMED